Relatively, low PD-L1 expression, reduced infiltration of CD8+ T lymphocytes and decreased immunogenicity in EGFR mutant NSCLC may be the potential mechanisms of poor response to ICIs [11, 12]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.